Sign in

Grace Macaulay

@gracemacaulay.bsky.social
23 followers 51 following 8 posts

Paediatric Specialty Trainee | Researcher | Academic Visitor University of Oxford Department of Paediatrics & Evelina London Children’s Hospital | MB ChB BMedSc(Hons) DCH |

PostsRepliesMedia
Grace Macaulay @gracemacaulay.bsky.social · 27/11/2025
Great to host the London School of Paediatrics Research Evening last week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team!🔬🩺✨ #londonschoolofpaediatrics #paediatricresearch
000
Reposted by Grace Macaulay
CIDRAP @cidrap.bsky.social · 31/10/2025
Oral vaccine protects against Salmonella Paratyphi in human challenge trial The two-dose oral vaccine had an efficacy of 73% in healthy volunteers who were exposed to Salmonella Paratyphi A, which causes paratyphoid fever. www.cidrap.umn.edu/s...
13212
Reposted by Grace Macaulay
NEJM.org @nejm.org · 31/10/2025
In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results: nej.md/3Lypfd5 #MedSky #IDSky
Kaplan–Meier curves for a diagnosis after challenge with S. Paratyphi A in a controlled human infection model.
173
Reposted by Grace Macaulay
NEJM.org @nejm.org · 02/11/2025
VASP phase 2b trial: No vaccine against Salmonella enterica serovar Paratyphi A is currently available. Research findings involving a candidate vaccine are summarized in a new Quick Take video. nej.md/43Gbmjc #MedSky #IDSky
A visual representation of the VASP phase 2b trial, which assessed a vaccine for protection against S. Paratyphi A infection.
042
Reposted by Grace Macaulay
NEJM.org @nejm.org · 05/11/2025
In a trial in healthy U.K. adults who were challenged with S. Paratyphi A in a controlled human infection model, two doses of the candidate vaccine CVD 1902 led to protection against S. Paratyphi A infection. Full VASP phase 2b trial results and Research Summary: nej.md/3Lypfd5  #MedSky
The New England Journal of Medicine                   
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 
A Research Summary based on McCann N et al. | 10.1056/NEJMoa2502992 | Published on October 30, 2025 

Visual representations of the patients in the trial and the treatments they were assigned.    

Read the full Research Summary at NEJM.org.
193
Grace Macaulay @gracemacaulay.bsky.social · 30/08/2025
New paper out 📣 Final results from the COV006 study - Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years 🦠📊 @grace-li.bsky.social @ox.ac.uk @ovg.ox.ac.uk www.sciencedirect.com/science/arti...
sciencedirect.com
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006)
Paediatric COVID-19 vaccination programmes were initiated in response to the coronavirus pandemic declared by the World Health Organisation (WHO) in 2…
010
Grace Macaulay @gracemacaulay.bsky.social · 02/05/2025
@cinarervanur.bsky.social thanks for contributing!
110
Grace Macaulay @gracemacaulay.bsky.social · 02/05/2025
Great to help host the London School of Paediatrics Research Evening this week — brilliant to see the research being done by trainees across London. Huge thanks to our speakers, attendees, and team. 🔬🩺✨ #londonschoolofpaediatrics #paediatricresearch
100
Grace Macaulay @gracemacaulay.bsky.social · 23/04/2025
Happening next week - celebrating paediatric research being done by amazing trainees! ⬇️👏
000
Grace Macaulay @gracemacaulay.bsky.social · 03/04/2025
Our next Paediatric Research Evening brought to you by the London School of Paediatrics🔬🌍🩺 If you’re a Paeds Trainee/Fellow/ACF and keen to attend, or present, sign-up via the link below or flick me a message! ⬇️ #paediatricresearch #childhealth
000
Grace Macaulay @gracemacaulay.bsky.social · 05/03/2025
Oooh is this presentation available to attend virtually? (Paeds trainee with a keen interest in research 🙋‍♀️)
010
Grace Macaulay @gracemacaulay.bsky.social · 17/02/2025
Great to see recruitment open 🦠🌏 Such an important study! @ox.ac.uk @ovg.ox.ac.uk
030
Reposted by Grace Macaulay
Sam Macaulay @samuelmacaulay.bsky.social · 11/02/2025
How can mesocosms help tackle grand ecological challenges in aquatic ecosystems? 🌊🌍 Check out our open-access Oikos Forum article, out today: 🔗 doi.org/10.1111/oik.... @oikosjournal.bsky.social
doi.org
Addressing grand ecological challenges in aquatic ecosystems: how can mesocosms be used to advance solutions?
Rapid and drastic anthropogenic impacts are affecting global biogeochemical processes and driving biodiversity loss across Earth's ecosystems. In aquatic ecosystems, species distributions are shiftin...
13219